These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24462865)

  • 1. Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
    Liu M; Ye J; Gao S; Fang W; Li H; Geng B; Zou J; Chen X; Chen S; Zhang L; Yue Z; Ma Y; Gao H; Li Z; Liu P
    Biochem Biophys Res Commun; 2014 Feb; 444(3):346-53. PubMed ID: 24462865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Liu M; Li Z; Chen GW; Li ZM; Wang LP; Ye JT; Luo HB; Liu PQ
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):14-22. PubMed ID: 24859603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
    Zhang Q; Tan Y; Zhang N; Yao F
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.
    Feng XJ; Gao H; Gao S; Li Z; Li H; Lu J; Wang JJ; Huang XY; Liu M; Zou J; Ye JT; Liu PQ
    Br J Pharmacol; 2015 Jun; 172(11):2852-63. PubMed ID: 25625556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1.
    Geng B; Cai Y; Gao S; Lu J; Zhang L; Zou J; Liu M; Yu S; Ye J; Liu P
    Biochem Biophys Res Commun; 2013 Jan; 430(3):944-50. PubMed ID: 23261455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
    Pillai JB; Gupta M; Rajamohan SB; Lang R; Raman J; Gupta MP
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1545-53. PubMed ID: 16632544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1.
    Zhang L; Zou J; Chai E; Qi Y; Zhang Y
    Eur J Pharmacol; 2014 Dec; 744():203-10. PubMed ID: 25281201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.
    Feng GS; Zhu CG; Li ZM; Wang PX; Huang Y; Liu M; He P; Lou LL; Chen SR; Liu PQ
    Acta Pharmacol Sin; 2017 May; 38(5):638-650. PubMed ID: 28239158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-alpha (TNF-alpha)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species.
    Zhang HS; Wang SQ
    J Mol Cell Cardiol; 2006 Jul; 41(1):138-48. PubMed ID: 16713603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
    Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
    Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways].
    Li ZY; Yang YH; Xing L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):698-703. PubMed ID: 24225244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
    Hu S; Cheng M; Guo X; Wang S; Liu B; Jiang H; Huang C; Wu G
    J Cell Mol Med; 2019 Apr; 23(4):2505-2516. PubMed ID: 30680929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
    Nakagami H; Takemoto M; Liao JK
    J Mol Cell Cardiol; 2003 Jul; 35(7):851-9. PubMed ID: 12818576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
    Guo WG; Su FF; Yuan LJ; Yang GD; Shi XQ; Li RY; Shu Q; Liu XT; Lu ZF; Zheng QS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):40-5. PubMed ID: 19515066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
    Hiromura M; Mori Y; Kohashi K; Terasaki M; Shinmura K; Negoro T; Kawashima H; Kogure M; Wachi T; Watanabe R; Sato K; Kushima H; Tomoyasu M; Nakano Y; Yamada Y; Watanabe T; Hirano T
    Circ J; 2016 Aug; 80(9):1988-97. PubMed ID: 27375170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
    Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways.
    Tang Y; Jacobi A; Vater C; Zou X; Stiehler M
    Biochem Pharmacol; 2014 Jul; 90(1):34-49. PubMed ID: 24780446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
    Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
    Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.